Skip to Content

93 7700 (Glimepiride and rosiglitazone maleate 2 mg / 8 mg)

Pill imprint 93 7700 has been identified as Glimepiride and rosiglitazone maleate 2 mg / 8 mg.

Glimepiride/rosiglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glimepiride/rosiglitazone 2 mg / 8 mg is not a controlled substance under the Controlled Substance Act (CSA).

Glimepiride and rosiglitazone maleate
Imprint:
93 7700
Strength:
2 mg / 8 mg
Color:
Pink
Shape:
Round
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide